Arsanis Biosciences Gmbh

X4 Pharmaceuticals (austria) Gmbh

X4 Pharmaceuticals, Inc.

Zoltán Magyarics

Eszter Nagy

Gábor Nagy

Adriana Badarau

Irina Mirkina

Valéria Szijárto

Jolanta Lukasiewicz

Luis Guachalla

Gerhild Zauner

Bianka Prinz

Astrid Teubenbacher

Manuel Zerbs

Zehra Visram

Michael Benjamin Battles

Harald Rouha

Lukas Stulik

Michaela Jaegerhofer

Ivana Dolezilkova

Jolanta Katarzyna Lukasiewicz

Bianka Dominique Prinz

Valeria Szijarto

The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR)strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

MDRspecific antibody

[object Object]

The subject relates to a cross-neutralizing antibody comprising at least one polyspecific binding site that binds to alpha-toxin (Hla) and at least one of the bi-component toxins of, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated conformational epitope recognized by a specific cross-neutralizing antibody.

Growing community of inventors

Vienna, Austria

Zoltán Magyarics